FT
DXCM icon

Fiduciary Trust’s DexCom DXCM Stock Holding History

Fiduciary Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$361K Sell
5,750
-595
-9% -$41.4K ﹤0.01% 679
2025
Q4 		$421K Sell
6,345
-402
-6% -$26K ﹤0.01% 615
2025
Q3 		$454K Sell
6,747
-440
-6% -$34.8K 0.01% 585
2025
Q2 		$627K Buy
7,187
+31
+0.4% +$2.43K 0.01% 491
2025
Q1 		$489K Buy
7,156
+517
+8% +$42.2K 0.01% 522
2024
Q4 		$516K Buy
6,639
+56
+0.9% +$4.15K 0.01% 469
2024
Q3 		$441K Sell
6,583
-9
-0.1% -$739 0.01% 489
2024
Q2 		$747K Hold
6,592
– – 0.01% 382
2024
Q1 		$914K Sell
6,592
-3
-0% -$377 0.01% 361
2023
Q4 		$818K Sell
6,595
-365
-5% -$37.3K 0.01% 371
2023
Q3 		$649K Sell
6,960
-2
-0% -$225 0.01% 386
2023
Q2 		$895K Sell
6,962
-137
-2% -$16.6K 0.02% 348
2023
Q1 		$825K Sell
7,099
-44
-0.6% -$4.92K 0.02% 359
2022
Q4 		$809K Sell
7,143
-111
-2% -$12.2K 0.02% 374
2022
Q3 		$584K Hold
7,254
– – 0.01% 414
2022
Q2 		$541K Sell
7,254
-50
-0.7% -$4.56K 0.01% 436
2022
Q1 		$934K Buy
7,304
+1,140
+18% +$125K 0.02% 357
2021
Q4 		$827K Sell
6,164
-576
-9% -$82.8K 0.01% 375
2021
Q3 		$921K Buy
6,740
+400
+6% +$50.4K 0.02% 348
2021
Q2 		$677K Buy
6,340
+200
+3% +$19.2K 0.01% 410
2021
Q1 		$552K Buy
6,140
+296
+5% +$27.8K 0.01% 438
2020
Q4 		$540K Buy
5,844
+732
+14% +$65.4K 0.01% 421
2020
Q3 		$527K Sell
5,112
-128
-2% -$13.4K 0.01% 388
2020
Q2 		$531K Buy
5,240
+100
+2% +$8.95K 0.01% 371
2020
Q1 		$346K Buy
5,140
+216
+4% +$13.4K 0.01% 403
2019
Q4 		$269K Sell
4,924
-8,068
-62% -$383K 0.01% 465
2019
Q3 		$485K Sell
12,992
-772
-6% -$30K 0.01% 375
2019
Q2 		$516K Sell
13,764
-900
-6% -$28.3K 0.01% 350
2019
Q1 		$437K Sell
14,664
-400
-3% -$14.1K 0.01% 367
2018
Q4 		$451K Sell
15,064
-636
-4% -$20.2K 0.01% 336
2018
Q3 		$561K Hold
15,700
– – 0.02% 320
2018
Q2 		$373K Sell
15,700
-480
-3% -$10.2K 0.01% 366
2018
Q1 		$300K Sell
16,180
-2,800
-15% -$41.4K 0.01% 385
2017
Q4 		$272K Sell
18,980
-9,100
-32% -$118K 0.01% 383
2017
Q3 		$343K Sell
28,080
-1,600
-5% -$28.3K 0.01% 364
2017
Q2 		$543K Sell
29,680
-4,120
-12% -$76.1K 0.02% 324
2017
Q1 		$716K Sell
33,800
-2,436
-7% -$47.5K 0.02% 292
2016
Q4 		$541K Sell
36,236
-10,672
-23% -$189K 0.02% 318
2016
Q3 		$1.03M Sell
46,908
-6,656
-12% -$148K 0.04% 248
2016
Q2 		$1.06M Buy
53,564
+7,884
+17% +$134K 0.04% 247
2016
Q1 		$776K Buy
+45,680
New +$763K 0.03% 289

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fiduciary Trust's DXCM Position: Q1 2026 in Review

Fiduciary Trust reduced its DexCom (DXCM) stake by 9.4% in Q1 2026, selling an estimated $41.4K and leaving 5,750 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Fiduciary Trust first reported a position in DXCM in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.06M in Q2 2016. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Fiduciary Trust held 5,750 shares of DexCom worth $361K as of Q1 2026.
  • Fiduciary Trust sold 595 DexCom shares in Q1 2026, an estimated $41.4K.
  • DexCom made up ﹤0.01% of Fiduciary Trust's portfolio in Q1 2026, its #679 holding.
  • Fiduciary Trust first reported a position in DexCom in Q1 2016 and has held it in 41 quarters since.
  • Fiduciary Trust's DexCom position peaked at $1.06M in Q2 2016.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.